Pharma Focus Asia
Agilent || Data Integrity
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Latest Issue
Get instant access to latest e-book

LATEST NEWSRead more...

25

Nov 2021

Amgen and Bushu Pharma Announce Expanded Supply Chain Partnership across Japan and Asia-Pacific Region

Bushu Pharmaceuticals Ltd has agreed on an expanded partnership with Amgen Inc and Amgen KK to provide its Gateway to Asia service to four countries across the AsiaPacific region as Amgens contract manufacturing organization CMO An integral factor in Amgens business growth in Japan Bushu Pharma has...

25

Nov 2021

GreenLight Biosciences and Samsung Biologics announce collaboration to build capacity for messenger RNA Vaccine Manufacturing

GreenLight Biosciences a biotechnology company dedicated to making ribonucleic acid RNA products affordable and accessible for human health and agriculture and Environmental Impact Acquisition Corp and Samsung Biologics KRX KS a leading global CDMO providing fully integrated endtoend contract develo...

24

Nov 2021

Valneva Signs Purchase Agreement with European Commission for its Inactivated COVID-19 Vaccine VLA2001

Valneva SE a specialty vaccine company today announced that it has signed an Advance Purchase Agreement APA with the European Commission EC to supply up to million doses of its inactivated COVID vaccine candidate VLA over two years The agreement follows the announcement made earlier this month that...

24

Nov 2021

Donaldson Company Acquires Solaris Biotechnology

Donaldson Company Inc a leading worldwide provider of innovative filtration products and solutions today announced it acquired Solaris Biotechnology Srl Solaris Solaris designs and manufactures bioprocessing equipment including bioreactors fermenters and tangential flow filtration systems for use in...

23

Nov 2021

Obseva Announces U.S. FDA Acceptance of New Drug Application for Linzagolix

Obseva SA a biopharmaceutical company developing and commercializing novel therapies to improve womens reproductive healthtoday announced that the New Drug Application NDA for linzagolix for the management of heavy menstrual bleeding associated with uterine fibroids in premenopausal women has been a...

23

Nov 2021

Vifor Pharma to spearhead development of vascular calcification field, through acquisition of Sanifit Therapeutics and Inositec AG

Vifor Pharma has announced the acquisition of Sanifit Therapeutics a Spanish clinicalstage cardiorenal biopharmaceutical company focused on treatments for endstage kidney disease patients with progressive vascular calcification disorders and Inositec AG a Swiss company developing firstinclass nondia...

press releasesRead more...

24

Nov 2021

Philogen Announces New Collaboration With Janssen To Discover Small Molecule Therapeutics

Philogen SpA a clinicalstage biotechnology company focused on antibody and small moleculebased targeted therapeutics today announces that its whollyowned Swiss subsidiary Philochem AG has entered into a new collaboration and option agreement with Janssen Biotech Inc one of the Janssen Pharmaceutical...

24

Nov 2021

Supernus Pharmaceuticals Completes Acquisition of Adamas Pharmaceuticals

Supernus Pharmaceuticals Inc today announced that it has successfully completed its previously announced acquisition of Adamas Pharmaceuticals Inc Adamas fits squarely within our corporate development strategy adding a latestage commercial product with significant revenue said Jack Khattar President...

23

Nov 2021

Eppendorf donates 20,000 euros to the EMBL to promote women working in science

Eppendorf SE donated euros to the European Molecular Biology Laboratory EMBL during an online presentation ceremony The funds are for the EMBL project Advancement of Women in Science which enables women scientists to begin managerial careers in scientific fields In her remarks thanking the company...

23

Nov 2021

Tonix Pharmaceuticals Announces FDA Clearance of the IND for Potentiated Intranasal Oxytocin (TNX-1900) for the Prevention of Migraine Headache in Chronic Migraineurs

Tonix Pharmaceuticals Holding Corp a clinicalstage biopharmaceutical company today announced the US Food and Drug Administration FDA has cleared the Investigational New Drug IND Application to support the initiation of a Phase study of TNX intranasal potentiated oxytocin for the prevention of migra...

23

Nov 2021

Takeda’s LIVTENCITYTM (maribavir) Approved by U.S. FDA as the First and Only Treatment for People Ages 12 and Older with Post-Transplant Cytomegalovirus (CMV), Refractory

Takeda Pharmaceutical Company Limited today announced that the US Food and Drug Administration FDA has approved LIVTENCITY maribavir for the treatment of adults and pediatric patients years of age or older and weighing at least kg with posttransplant cytomegalovirus CMV infectiondisease that is re...

22

Nov 2021

BioCorRx Acquires Intellectual Property for Drug Delivery

BioCorRx Inc a developer and provider of innovative treatment programs for substance abuse and related disorders today announced that the Company has acquired a patent application from Calista Therapeutics The current application was filed with the US Patent and Trademark Office USPTO covering soli...

EventsRead more...

01 - 02

Dec 2021

Pharmaceuticals Formulation and Drug Delivery

Kyoto, Japan

02 - 04

Dec 2021

2nd Joint Congress of the INS European Chapters

Paris

02 - 03

Dec 2021

Nanomaterials & Nanotechnololgy

online

03 - 04

Dec 2021

Enzymology and Cell Biology

London

06 - 07

Dec 2021

2nd Euro Diabetes and Endocrinology Congress

Plenareno
Holiday Inn Rome

07 - 08

Dec 2021

Pharmacology 2021

Dubai

09 - 10

Dec 2021

Nanomedicine and Drug Delivery

Abu Dhabi

16 - 17

Dec 2021

Emirates Surgical Pathology Conference 2021

Dubai

Testing The World
Development and Validation of a Platform Assay Method Using Variable Pathlength Technology for Oligonucleotide Drug Products
Catalent Asia-Pacific Clinical Supply Solutions
SGS - Health Science
Horizon - CHOSOURCE advances biotherapeutic production
MasterControl - The Never-Normal Future of Manufacturing
Medical Fair Thailand 2022
Meco - 90 years
Emirates Surgical Pathology Conference 2021
Saving Money, Saving Time In Pharma Operations

TOP ARTICLES

  • 4

    Metabolic Stability

     The liability of a drug substance to the metabolism is referred to as metabolic stability The liver uses CYPme...

KNOWLEDGE BANK

  • Interviews

    University of Lincoln, UK

    Senior Lecturer, School of Pharmacy

    Ishwar Singh is a Senior Lecturer in Biological Chemistry at the School of Pharmacy University of Lincoln Prior to Lincoln he had held many prestigious fellowships such as the Alexander von Humboldt fellowship Germany and Senior Research Fellowship DANIDA Denmark and CSIR India He is an organic chemist He has developed bioconjugations for DNA RNA and polymer modifications in water He is currently...

  • Articles

    Data-Enriched Edible Pharmaceuticals (DEEP) as Patient-Tailored Drug Products

    Patienttailored treatment can be a challenge with conventional product design principles such as oral products based on tableting There are several reasons for that First of all there is restricted flexibility in the dosage strengths that are available on the market Administration of an inappropriate dose can lead to adverse drug reactions or lack of therapeutic effect

  • Research Insights

    Insights into CYP2B6-mediated drug–drug interactions

    Abstract Mounting evidence demonstrates that CYPB plays a much larger role in human drug metabolism than was previously believed The discovery of multiple important substrates of CYPB as well as polymorphic differences has sparked increasing interest in the genetic and xenobiotic factors contributing to the expression and function of the enzyme The expression

  • White Papers

    Supplier Diversity in Pharmaceutical R&D

    Procurement decisions are no longer limited to cost savings quality and time sustainability is the new addition to procurement decision making Risks arising from environmental and social factors compliance value creation and external demand are driving sustainable procurement Supplier Diversity an aspect that impacts the sustainability of procurement has gained much importance today This whitepape...

Advisory Board

Stella Stergiopoulos

Stella
Sanjoy Ray

Sanjoy Ray
Rustom Mody

Rustom
Phil Kaminsky

Phil
Neil J Campbell

Neil J
Laurence Flint

Laurence
Kenneth I Kaitin

Kenneth I
Georg C Terstappen

Georg C
Frank A Jaeger

Frank A
Douglas Meyer

Douglas
Christopher-Paul Milne

Christopher-
Alan S Louie

Alan S Louie

EDITORIAL SECTION

  • EXPERT Talk

    PHARMA LOGISTICS TRENDS

    Pharma logistics is undergoing profound change throughout Asia as the ageing population drives a growing need for new pharma solutions together with s...